Table 6.
Outcomes | Nonobstructive HCM | Labile HCM | Obstructive HCM |
---|---|---|---|
Need for SRT | − | + | ++ |
Clinical outcomes | |||
AF | + | + | +++ |
VT/VF | +++ | ++ | + |
Heart failure | ++ | + | ++ |
Death | + | +/− | + |
Overall risk | Intermediate | Low | High |
The left ventricular outflow tract pressure gradients were as follows: nonobstructive HCM, at rest, <30 mm Hg, and provoked, <30 mm Hg; labile HCM, at rest, <30 mm Hg, and provoked, ≥30 mm Hg; and obstructive HCM, at rest, ≥30 mm Hg, and provoked, ≥30 mm Hg. + indicates low risk; ++, intermediate risk; +++, high risk; −, not applicable; AF, atrial fibrillation; HCM, hypertrophic cardiomyopathy; SRT, septal reduction therapy; and VT/VF, ventricular tachycardia/ventricular fibrillation.